In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.
Cells
; 11(16)2022 08 11.
Article
in En
| MEDLINE
| ID: mdl-36010573
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Long QT Syndrome
/
TRPM Cation Channels
/
Induced Pluripotent Stem Cells
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
Cells
Year:
2022
Type:
Article
Affiliation country:
China